Home » Topics » Nephrology, BioWorld Science

Nephrology, BioWorld Science
RSS

FemSoft Insert now commercially available in U.S. for treatment of incontinence

Jan. 19, 2000

Pharmacia & Upjohn and Searle to copromote Detrol

Jan. 11, 2000

FDA informs Urologix of new developments concerning the Targis System

Jan. 6, 2000

Injectable levocarnitine approved for use in dialysis in U.S.

Dec. 28, 1999

Once-daily oxybutynin assessed in urinary urge incontinence

Dec. 27, 1999

Vivus seeks FDA approval for new impotence drug

Dec. 23, 1999

Vasomax progress updated by Zonagen

Dec. 22, 1999

NexMed initiates phase II trials of alprostadil cream in U.S.

Dec. 22, 1999

Milestone for Gene Logic in kidney disease collaboration

Dec. 21, 1999

Herbomineral preparation shows efficacy in animal model of BPH

Dec. 15, 1999

Popular Stories

Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
AA meeting of minds as PTC, Novartis push votoplam in HD
BioWorld
What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...
Innervation can slow, as well as speed, tumor growth, study finds
BioWorld
Innervation by the sympathetic nervous system is typically a boon to tumors. But researchers from Weill Cornell Medicine and colleagues have shown that in some...
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...